Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ABBV compared with BMY: revenue, margins and what each company keeps, and the suppliers and customers both name
ABBV
AbbVie Inc.
Change
Mkt cap
Revenue
Revenue
BMY
Bristol Myers Squibb Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
ABBV
AbbVie Inc.
vs
BMY
Bristol Myers Squibb Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
ABBV
0 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±3.5%
▲
+1.41%
×0.40
Q2 FY26
±3.5%
▼
−2.51%
×0.71
Q1 FY26
±4.0%
▲
+3.14%
×0.78
Feb 4 '26
±3.9%
▼
−3.79%
×0.97
BMY
1 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±3.6%
▲
+1.35%
×0.39
Q2 FY26
±3.7%
▲
+2.79%
×0.76
= implied
ABBV realized, solid
BMY realized, hatched
One scale, both sides: full bar = 6%
× = |realized| ÷ implied
Source: market data
Q1 FY26
±4.1%
▲
+5.21%
×1.27
Feb 5 '26
±3.8%
▲
+3.30%
×0.87
ABBV
AbbVie Inc.
Change
285.97
▼
−0.99%
· post 285.21
Mkt cap
$510.4B
Revenue
$17.4B
Q3 FY26
Revenue
$61.2B
FY25
BMY
Bristol Myers Squibb Co
Change
61.71
▼
−2.08%
· post 61.73
Closed
Nov 3 '26
Mkt cap
$128.8B
Revenue
$13.1B
Q3 FY26
Revenue
$48.2B
FY25
vs
Compare
Closed
Nov 3 '26
ABBV
AbbVie Inc.
vs
BMY
Bristol Myers Squibb Co
285.97
▼
−0.99%
post 285.21
Price
61.71
▼
−2.08%
post 61.73
$510.4B
Mkt cap
$128.8B
Q3 FY26
$17.4B
Revenue
$13.1B
Q3 FY26
FY25
$61.2B
Revenue
$48.2B
FY25
Change
Change
ABBV
285.97
▼
−0.99%
vs
BMY
61.71
▼
−2.08%
Closed
Nov 3 '26